Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.0…

Overview of attention for article published in Lancet Oncology, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
twitter: 51 X users

facebook: 1 Facebook page
guideline: 4 clinical guideline sources

Readers on

mendeley: 217 Mendeley

So far, Altmetric has seen 6 news stories from 5 outlets.

Longer Androgen Suppression With RT Superior for Advanced PCa

Medical Health News, 04 Feb 2019

Share this content: Study finds 18 vs 6 months of androgen suppression and radiotherapy for locally advanced prostate cancer is…

RADAR Trial: Short- vs Intermediate-Term Androgen Suppression and Zoledronic Acid in Locally Advanced Prostate Cancer

The ASCO Post, 29 Jan 2019

By Matthew Stenger Posted: 1/2/2019 12:22:25 PM Last Updated: 1/2/2019 12:22:25 PM 18 months of androgen suppression plus…

Intermediate-term androgen suppression benefits higher risk prostate cancer

Medical Health News, 02 Jan 2019

medwireNews : Patients treated with 18 months of androgen suppression plus radiotherapy have a significantly lower rate of…

Intermediate-term androgen suppression benefits higher risk prostate cancer

medwireNews, 02 Jan 2019

medwireNews: Patients treated with 18months of androgen suppression plus radiotherapy have a significantly lower rate of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.